3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
38
Breast Neoplasms
31
Lung Neoplasms
25
Colorectal Neoplasms
15
Prostatic Neoplasms
13
Pancreatic Neoplasms
11
Ovarian Neoplasms
11
Head and Neck Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Sarcoma
8
Colonic Neoplasms
8
Uterine Cervical Neoplasms
7
Melanoma
7
Glioma
7
Esophageal Neoplasms
7
Carcinoma, Hepatocellular
7
Lymphoma
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neoplastic Cells, Circulating
5
Multiple Myeloma
5
Endometrial Neoplasms
5
Brain Neoplasms
5
Neoplasm, Residual
4
Gastrointestinal Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Renal Cell
4
Adenocarcinoma
4
Thrombosis
3
Skin Neoplasms
3
Interventions
Temozolomide
3
Cyclophosphamide
3
Etoposide
2
ibrutinib
1
gallium Ga 68 dotatate
1
fludarabine
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Vincristine
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy
1
ONC206
1
Nivolumab
1
Mesna
1
Isotretinoin
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eflornithine
1
Drug Therapy
1
Cisplatin
1
Celecoxib
1
Carboplatin
1
Blood Specimen Collection
1
Automobiles
1
1-methyltryptophan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neuroectodermal Tumors, Primitive
×
Blood Specimen Collection
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled